Human Vγ9Vδ2 T cells: promising new leads for immunotherapy of infections and tumors

Current Opinion in Immunology

Volumn 18, Issue 5, 2006, Pages 539-546

  Bonneville, Marc ^a   Scotet, Emmanuel ^a  

^a INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOHYDRIN PYROPHOSPHATE; INTERLEUKIN 2; ISOPRENOID; PYROPHOSPHORIC ACID DERIVATIVE; RECOMBINANT INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; BACTERICIDAL ACTIVITY; CANCER IMMUNOTHERAPY; CELL MATURATION; CLINICAL TRIAL; CYTOLYSIS; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION; NATURAL KILLER T CELL; NONHUMAN; REVIEW; SOLID TUMOR; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR; IMMUNOLOGY; IMMUNOTHERAPY; NEOPLASM;

HUMANS; IMMUNOTHERAPY; INFECTION; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS;

EID: 33748131230     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2006.07.002     Document Type: Review

References (50)

1. Hayday A.C. γδ cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 18 (2000) 975-1026
2. Haas W., Pereira P., and Tonegawa S. γ/δ cells. Annu Rev Immunol 11 (1993) 637-685
3. Chien Y.H., Jores R., and Crowley M.P. Recognition by γ/δ T cells. Annu Rev Immunol 14 (1996) 511-532
4. Bonneville M., and Fournie J.J. Sensing cell stress and transformation through Vγ9Vδ2 T cell-mediated recognition of the isoprenoid pathway metabolites. Microbes Infect 7 (2005) 503-509
5. Born W.K., Reardon C.L., and O'Brien R.L. The function of γδ T cells in innate immunity. Curr Opin Immunol 18 (2006) 31-38
6. De Rosa S.C., Andrus J.P., Perfetto S.P., Mantovani J.J., Herzenberg L.A., and Roederer M. Ontogeny of γδ T cells in humans. J Immunol 172 (2004) 1637-1645
7. Davodeau F., Peyrat M.A., Hallet M.M., Houde I., Vie H., and Bonneville M. Peripheral selection of antigen receptor junctional features in a major human γδ subset. Eur J Immunol 23 (1993) 804-808
8. Jomaa H., Feurle J., Luhs K., Kunzmann V., Tony H.P., Herderich M., and Wilhelm M. Vγ9/Vδ2 T cell activation induced by bacterial low molecular mass compounds depends on the 1-deoxy-d-xylulose 5-phosphate pathway of isoprenoid biosynthesis. FEMS Immunol Med Microbiol 25 (1999) 371-378
9. Begley M., Gahan C.G., Kollas A.K., Hintz M., Hill C., Jomaa H., and Eberl M. The interplay between classical and alternative isoprenoid biosynthesis controls γδ T cell bioactivity of Listeria monocytogenes. FEBS Lett 561 (2004) 99-104
10. Tanaka Y., Morita C.T., Nieves E., Brenner M.B., and Bloom B.R. Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 375 (1995) 155-158
11. Devilder M.C., Maillet S., Bouyge-Moreau I., Donnadieu E., Bonneville M., and Scotet E. Potentiation of antigen-stimulated Vγ9Vδ2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation. J Immunol 176 (2006) 1386-1393. This study shows that immature DCs are much more potent stimulators of Vγ9Vδ2 T-cell cytokine responses than other APCs, including mature DCs, thus pointing to an important role played by γδ T cells in DC maturation and priming of T-cell responses.
12. Gober H.J., Kistowska M., Angman L., Jeno P., Mori L., and De Libero G. Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 197 (2003) 163-168
13. Das H., Groh V., Kuijl C., Sugita M., Morita C.T., Spies T., and Bukowski J.F. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity 15 (2001) 83-93
14. Rincon-Orozco B., Kunzmann V., Wrobel P., Kabelitz D., Steinle A., and Herrmann T. Activation of Vγ9Vδ2 T cells by NKG2D. J Immunol 175 (2005) 2144-2151
15. Viey E., Fromont G., Escudier B., Morel Y., Da Rocha S., Chouaib S., and Caignard A. Phosphostim-activated γδ T cells kill autologous metastatic renal cell carcinoma. J Immunol 174 (2005) 1338-1347
16. Corvaisier M., Moreau-Aubry A., Diez E., Bennouna J., Mosnier J.F., Scotet E., Bonneville M., and Jotereau F. Vγ9Vδ2 T cell response to colon carcinoma cells. J Immunol 175 (2005) 5481-5488
17. Bukowski J.F., Morita C.T., and Brenner M.B. Human γδ T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity 11 (1999) 57-65
18. Thompson K., Rojas-Navea J., and Rogers M.J. Alkylamines cause Vγ9Vδ2 T-cell activation and proliferation by inhibiting the mevalonate pathway. Blood 107 (2006) 651-654. This study demonstrates that, like bisphosphonate, alkylamines activate Vγ9Vδ2 T cells through blockade of the mevalonate pathway and subsequent intracellular IPP accumulation. This provides a unifying view of Vγ9Vδ2 T-cell activation by phosphoantigens.
19. Poccia F., Agrati C., Martini F., Capobianchi M.R., Wallace M., and Malkovsky M. Antiviral reactivities of γδ T cells. Microbes Infect 7 (2005) 518-528. In this recent review, the authors extensively analyzed the role of γδ T cells in antiviral immunosurveillance.
20. Lang F., Peyrat M.A., Constant P., Davodeau F., David-Ameline J., Poquet Y., Vie H., Fournie J.J., and Bonneville M. Early activation of human Vγ9Vδ2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J Immunol 154 (1995) 5986-5994
21. Wadhwa R., Yaguchi T., Hasan M.K., Taira K., and Kaul S.C. Mortalin-MPD (mevalonate pyrophosphate decarboxylase) interactions and their role in control of cellular proliferation. Biochem Biophys Res Commun 302 (2003) 735-742
22. Scotet E., Martinez L.O., Grant E., Barbaras R., Jeno P., Guiraud M., Monsarrat B., Saulquin X., Maillet S., Esteve J.P., et al. Tumor recognition following Vγ9Vδ2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 22 (2005) 71-80. In this study, the authors provide the first evidence for cognate interactions between the Vγ9Vδ2 TCR and AS complex. It describes a new class of tumor antigens derived from mitochondrial enzymes that are recognized by T cells.
23. Burrell H.E., Wlodarski B., Foster B.J., Buckley K.A., Sharpe G.R., Quayle J.M., Simpson A.W., and Gallagher J.A. Human keratinocytes release ATP and utilize three mechanisms for nucleotide interconversion at the cell surface. J Biol Chem 280 (2005) 29667-29676
24. Ragno S., Romano M., Howell S., Pappin D.J., Jenner P.J., and Colston M.J. Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach. Immunology 104 (2001) 99-108
25. Moser T.L., Kenan D.J., Ashley T.A., Roy J.A., Goodman M.D., Misra U.K., Cheek D.J., and Pizzo S.V. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA 98 (2001) 6656-6661
26. Monkkonen H., Auriola S., Lehenkari P., Kellinsalmi M., Hassinen I.E., Vepsalainen J., and Monkkonen J. A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates. Br J Pharmacol 147 (2006) 437-445
27. Constant P., Davodeau F., Peyrat M.A., Poquet Y., Puzo G., Bonneville M., and Fournie J.J. Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 264 (1994) 267-270
28. Glatzel A., Wesch D., Schiemann F., Brandt E., Janssen O., and Kabelitz D. Patterns of chemokine receptor expression on peripheral blood γδ T lymphocytes: strong expression of CCR5 is a selective feature of Vδ2/Vγ9 γδ T cells. J Immunol 168 (2002) 4920-4929
29. Brandes M., Willimann K., Lang A.B., Nam K.H., Jin C., Brenner M.B., Morita C.T., and Moser B. Flexible migration program regulates γδ T-cell involvement in humoral immunity. Blood 102 (2003) 3693-3701
30. Battistini L., Caccamo N., Borsellino G., Meraviglia S., Angelini D.F., Dieli F., Cencioni M.T., and Salerno A. Homing and memory patterns of human γδ T cells in physiopathological situations. Microbes Infect 7 (2005) 510-517
31. Brigl M., and Brenner M.B. CD1: antigen presentation and T cell function. Annu Rev Immunol 22 (2004) 817-890
32. Munz C., Steinman R.M., and Fujii S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med 202 (2005) 203-207
33. Conti L., Casetti R., Cardone M., Varano B., Martino A., Belardelli F., Poccia F., and Gessani S. Reciprocal activating interaction between dendritic cells and pamidronate-stimulated γδ T cells: role of CD86 and inflammatory cytokines. J Immunol 174 (2005) 252-260
34. Collins C., Wolfe J., Roessner K., Shi C., Sigal L.H., and Budd R.C. Lyme arthritis synovial γδ T cells instruct dendritic cells via fas ligand. J Immunol 175 (2005) 5656-5665. This study provides a demonstration of an unexpected mechanism of DC maturation, which is mediated by γδ T cells through Fas engagement.
35. Yamashita S., Tanaka Y., Tsutsumi S., Aburatani H., Minato N., and Ihara S. Analysis of mechanism for human γδ T cell recognition of nonpeptide antigens. Biochem Biophys Res Commun 334 (2005) 349-360
36. Brandes M., Willimann K., and Moser B. Professional antigen-presentation function by human γδ T cells. Science 309 (2005) 264-268. The authors report that activated Vγ9Vδ2 T cells, like classical and well described APCs, such as DCs, can not only upregulate surface co-stimulators but also efficiently process and present antigens. These unexpected results thus suggest that Vγ9Vδ2 T cells could directly participate in the induction of adaptative immune response, by priming of naïve αβ T cells.
37. Wesch D., Glatzel A., and Kabelitz D. Differentiation of resting human peripheral blood γδ T cells toward Th1- or Th2-phenotype. Cell Immunol 212 (2001) 110-117
38. Ordway D.J., Pinto L., Costa L., Martins M., Leandro C., Viveiros M., Amaral L., Arroz M.J., Ventura F.A., and Dockrell H.M. γδ T cell responses associated with the development of tuberculosis in health care workers. FEMS Immunol Med Microbiol 43 (2005) 339-350
39. Workalemahu G., Foerster M., and Kroegel C. Expression and synthesis of fibroblast growth factor-9 in human γδ T-lymphocytes. Response to isopentenyl pyrophosphate and TGF-β1/IL-15. J Leukoc Biol 75 (2004) 657-663
40. Workalemahu G., Foerster M., and Kroegel C. Expression of metalloproteinase-7 (matrilysin) in human blood and bronchoalveolar γδ T-lymphocytes. Selective upregulation by the soluble non-peptidic mycobacterial phosphoantigen (isopentenyl pyrophosphate). J Cell Physiol 207 (2006) 67-74
41. Jameson J.M., Sharp L.L., Witherden D.A., and Havran W.L. Regulation of skin cell homeostasis by γδ T cells. Front Biosci 9 (2004) 2640-2651
42. Kabelitz D., Wesch D., Pitters E., and Zoller M. Characterization of tumor reactivity of human Vγ9Vδ2 γδ T cells in vitro and in SCID mice in vivo. J Immunol 173 (2004) 6767-6776
43. Lozupone F., Pende D., Burgio V.L., Castelli C., Spada M., Venditti M., Luciani F., Lugini L., Federici C., Ramoni C., et al. Effect of human natural killer and γδ T cells on the growth of human autologous melanoma xenografts in SCID mice. Cancer Res 64 (2004) 378-385
44. Sicard H., Ingoure S., Luciani B., Serraz C., Fournie J.J., Bonneville M., Tiollier J., and Romagne F. In vivo immunomanipulation of Vγ9Vδ2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J Immunol 175 (2005) 5471-5480. This article demonstrates efficient in vivo expansion and activation of Vγ9Vδ2 T cells following injection of a synthetic phosphoAg and IL-2 in monkeys, as well as exhaustion of Vγ9Vδ2 T cell responses upon repeated treatments. This forms the basis of subsequent clinical trials that aim to use phosphoAg to activate Vγ9Vδ2 T cells.
45. Casetti R., Perretta G., Taglioni A., Mattei M., Colizzi V., Dieli F., D'Offizi G., Malkovsky M., and Poccia F. Drug-induced expansion and differentiation of Vγ9Vδ2 T cells in vivo: the role of exogenous IL-2. J Immunol 175 (2005) 1593-1598
46. Wilhelm M., Kunzmann V., Eckstein S., Reimer P., Weissinger F., Ruediger T., and Tony H.P. γδ T cells for immune therapy of patients with lymphoid malignancies. Blood 102 (2003) 200-206
47. Wesch D., Kabelitz D., Friese K., and Pechhold K. Mycobacteria-reactive γδ T cells in HIV-infected individuals: lack of Vγ9 cell responsiveness is due to deficiency of antigen-specific CD4 T helper type 1 cells. Eur J Immunol 26 (1996) 557-562
48. Caccamo N., Meraviglia S., Ferlazzo V., Angelini D., Borsellino G., Poccia F., Battistini L., Dieli F., and Salerno A. Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vγ9Vδ2 naïve, memory and effector T cell subsets. Eur J Immunol 35 (2005) 1764-1772
49. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., Raulet D.H., Lanier L.L., Groh V., Spies T., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21 (2004) 357-366
50. Bendelac A., Bonneville M., and Kearney J.F. Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 1 (2001) 177-186